
Is the US Hemp Ban Punishing the Wrong People?
This article was written for Business of Cannabis by Scott Mazza, Co-Founder of Vitality CBD and Certified Headies Uncertainty isn’t

This article was written for Business of Cannabis by Scott Mazza, Co-Founder of Vitality CBD and Certified Headies Uncertainty isn’t

In April 2025, the Italian government used emergency constitutional powers to bypass parliament and reclassify non-intoxicating hemp as a narcotic,

New Zealand’s medical cannabis market grew a further 25% in 2025, according to the latest official figures, seeing the country

Sorting Evidence from Anecdote As global cannabis research accelerates, the number of published studies has never been higher, but not

Cannabis is now one of the most frequently discussed therapeutic agents in modern medicine, driven by expanding access programmes and

Legal cannabis cultivators like Bovenschen’s Pure Sunfarms are required by law to label every flower product with its total THC content, measured “in discrete units.” That’s despite a recent study showing cannabis flower’s THC content can vary by as much as one-third – even within the same plant.

Slovenia is making its own move toward legalisation, at least in part, for personal consumption. As reported two weeks ago by the Slovenian news agency Index, members of Slovenia’s governing coalition, comprising the Freedom Movement (Gibanje Svoboda) and the Left (Levica), have submitted a draft bill to parliament aimed at regulating personal cannabis use. Natasa Sukic, a member of parliament from Levica, said the goal is to implement the will of the voters.

This morning, the UK’s Food Standards Agency (FSA) announced some significant updates to its multi-year CBD Novel Foods approvals process,

One of the key differences between medical cannabis and other more traditional treatments is the highly personalised nature of how each patient is affected.

David Sergi and Kyler Rucker of Sergi and Associates, a San Marcos-based law firm Across the state, lawful hemp retailers

Yesterday hearings on two bills which threaten to ‘dismantle’ Texas’s thriving hemp industry ran for a marathon of 18 hours, with the majority of participants testifying against the punitive measures.

The freewheeling days for hemp-derived THC in America appear to be dwindling.

Texas has taken one step closer to becoming the latest US state to impose a blanket ban on intoxicating hemp products, a move which could destroy ‘90-95%’ of the state’s thriving hemp industry.

A new study in California’s booming intoxicating hemp market has painted a damning picture of the largely unregulated products which have swept across the US in recent years.

Kingdom Therapeutics, a UK-Irish biotech company, has passed a ‘major milestone’ in its ambitious journey towards launching clinical trials into cannabis and Autism Spectrum Disorder (ASD)

Canada’s pioneering Cannabis Data Gathering Program has published the results of a new study showing a shocking discrepancy between advertised and actual THC amounts in its consumer market.

Senator Charles Perry has officially filed Senate Bill 3 (SB 3), a sweeping piece of legislation that, while introducing some consumer protections, ultimately seeks to re-criminalize THC and nearly all other cannabinoids in Texas’ booming hemp market.

The highly anticipated US Farm Bill has been pushed back until next year, leaving the future regulation of intoxicating hemp substances in the hands of individual states.